However, the serum ApoA1 and ApoB levels were positively correlated with the degree of cognitive function in patients with schizophrenia, indicating that serum ApoA1 and ApoB levels may be biomarkers of general cognitive function in schizophrenia patients. This evidence concerns the gene APOA1 and schizophrenia.